HIV-infected patients with anal carcinoma who subsequently developed oral squamous cell carcinoma: Report of 2 cases

Journal of the International Association of Physicians in AIDS Care

Volumn 7, Issue 6, 2008, Pages 306-310

  Chaiyachati, Krisda ^a   Cinti, Sandro K ^a   Kauffman, Carol A ^a   Riddell, James ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

AIDS; cancer; HIV; HPV

Indexed keywords

ANUS TUMOR; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MOUTH TUMOR; PAPILLOMA VIRUS; SECOND CANCER; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION;

ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 62249190695     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109708327490     Document Type: Article

References (35)

1. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006 ; 145: 397-406. (Pubitemid 46768570)
2. Burgi A., Brodine S., Wegner S., et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005 ; 104: 1505-1511. (Pubitemid 41356166)
3. Grulich AE, Wan X., Law MG, Coates M., Kaldor JM Risk of cancer in people with AIDS. AIDS. 1999 ; 13: 839-843. (Pubitemid 29224587)
4. Frisch M., Biggar RJ, Engels EA, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001 ; 285: 1736-1745. (Pubitemid 32259908)
5. Herida M., Mary-Krause M., Kaphan R., et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003 ; 21: 3447-3453. (Pubitemid 46594077)
6. Patel P., Hansen D., Novak R., et al. Incidence of AIDS defining and non-AIDS defining malignancies among HIV-infected persons. Poster presented at: 13th Conference on Retroviruses and Opportunistic Infections ; February 5-8, 2006 ; Denver, CO. Abstract 803.
7. Cinti SK, Gandhi T., Riddell J. 4th. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier? AIDS Read. 2008 ; 18: 18-20, 26-32.
8. Singh B., Balwally AN, Shaha AR, et al. Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection [published correction appears in Arch Otolaryngol Head Neck Surg. 1996: 122: 944 ]. Arch Otolaryngol Head Neck Surg. 1996 ; 122: 639-643.
9. Pantanowitz L., Schlecht HP, Dezube BJ The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol. 2006 ; 18: 469-478. (Pubitemid 44199843)
10. Frisch M., Biggar RJ, Goedert JJ Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000 ; 92: 1500-1510.
11. Chiao EY, Giordano TP, Palefsky JM, Tyring S., El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis. 2006 ; 43: 223-233.
12. Jin L., Lloyd RV In situ hybridization: methods and applications. J Clin Lab Anal. 1997 ; 11: 2-9. (Pubitemid 27053382)
13. Palefsky JM, Holly E., Ralston MR, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998 ; 1777: 361-367. (Pubitemid 28063760)
14. Critchlow CW, Hawes SE, Kuypers JM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS. 1998 ; 12: 1177-1184. (Pubitemid 28302420)
15. Chin-Hong PV, Palefsky PM Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther. 2005 ; 18: 67-76. (Pubitemid 40685549)
16. Piketty C., Darragh TM, Da Costa M., et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003 ; 138: 453-459.
17. Piketty C., Kazatchkine MD Human papillomavirus-related cervical and anal disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Curr HIV/AIDS Rep. 2005 ; 2: 140-145.
18. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998 ; 90: 1626-1636. (Pubitemid 28523437)
19. Hafkamp HC, Manni JJ, Speel EJ Role of the human papillomavirus in the development of head and neck squamous cell carcinoma. Acta Otolaryngol. 2004 ; 124: 520-526. (Pubitemid 38797618)
20. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005 ; 32 (suppl 1). S59 - S66.
21. D'Souza G., Kreimer AR, Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007 ; 356: 1944-1956. (Pubitemid 46740304)
22. Kreimer AR, Alberg AJ, Daniel R., et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004 ; 189: 686-698. (Pubitemid 38270923)
23. Kirby TO, Allen ME, Alvarez RD, Hoesley CJ, Huh WK High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in population with human immunodeficiency virus. J Low Genit Tract Dis. 2004 ; 8: 298-303. (Pubitemid 39332205)
24. Ritchie JM, Smit EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003 ; 104: 336-344. (Pubitemid 36249816)
25. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N., Palefsky JM Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 2001 ; 93: 843-849. (Pubitemid 32586612)
26. Sullivan PS, Juhasz M., Brooks J., Wolfe M., and the Adult/Adolescent Spectrum of HIV Disease Study Group, CDC, Atlanta. Incidence and association of anorectal cancers in persons with HIV infection. Paper presented at: Eleventh Conference on Retroviruses and Opportunistic Infections ; February 8-11, 2004 ; San Francisco, CA. Abstract 777.
27. Del Mistro A., Chieco BL HPV-related neoplasms in HIV-infected individuals. Eur J Cancer. 2001 ; 37: 1227-1235.
28. Singh B., Sabin S., Rofim O., Shaha A., Har-El G., Lucente FE Alterations in head and neck cancer occurring in HIV infected patients-results of a pilot, longitudinal, prospective study. Acta Oncol. 1999 ; 38: 1047-1050. (Pubitemid 30033028)
29. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol. 2001 ; 184: 538-543. (Pubitemid 32234963)
30. Piketty C., Selinger-Leneman H., Grabar S., et al, for the Fhdh-Anrs Co 4. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008 ; 22: 1203-1211.
31. Hesselink AT, van den Brule AJ, Brink AA, et al. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer. 2004 ; 102: 11-18. (Pubitemid 38209568)
32. Garland SM, Hernandez-Avila M., Wheeler CM, et al, Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007 ; 356: 1928-1943.
33. Panther LA, Schlecht HP, Dezube BJ Spectrum of human papillomavirus- related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Read. 2005 ; 15: 79-82, 85-88, 91.
34. Reisinger KS, Block SL, Lazcano-Ponce E., et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J. 2007 ; 26: 201-209. (Pubitemid 46340765)
35. Block SL, Nolan T., Sattler C., et al, Protocol 016 Study Group. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006 ; 118: 2135-2145. (Pubitemid 46393698)